Revenio Group Oyj announced that Olli-Pekka Salovaara, Revenio Group Corporation's long-term President & CEO resigned on 31 December 2016. At the same time, he resigned from board membership in the subsidiaries Icare Finland Oy, Revenio Research Oy, Done Medical Oy and Oscare Medical Oy. Timo Hildén, who assumed the position of the Group's new President & CEO on 1 January 2017 and has been a deputy member on the boards of Icare Finland Oy, Revenio Research Oy and Done Medical Oy will become an ordinary member of these boards, and Robin Pulkkinen, the Group's CFO, will be appointed a deputy member of the boards.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.59 EUR | +0.33% |
|
+0.07% | +1.40% |
04-25 | Transcript : Revenio Group Oyj, Q1 2024 Earnings Call, Apr 25, 2024 | |
04-24 | Revenio Group Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.40% | 781M | |
-34.96% | 14.88B | |
-54.19% | 2.26B | |
+19.59% | 1.89B | |
-8.65% | 1.52B | |
+17.88% | 1.19B | |
-24.23% | 871M | |
-34.22% | 750M | |
-29.46% | 591M | |
+18.16% | 560M |
- Stock Market
- Equities
- REG1V Stock
- News Revenio Group Oyj
- Revenio Group Oyj Announces Management Changes